Beijing SBS Genetech Co., Ltd. is a pioneering biotechnology company based in China, dedicated to providing advanced scientific solutions to biological researchers. Since its establishment in 2000, the company has focused on custom oligonucleotide synthesis, gene synthesis, and custom peptide synthesis. Over the years, the company has expanded its offerings to include a diverse range of products such as DNA synthesis products, nucleic acid isolation & purification kits, DNA molecular weight markers, isothermal amplification products, and PCR, RNA, and gene manipulation solutions. Having established a dominant position in these fields, the company has collaborated with global scientists, resulting in the inclusion of its products in thousands of publications in prestigious academic journals like Science, Cell, Cancer Cell, and Cell Metabolism. Beijing SBS Genetech Co., Ltd. has played a pivotal role in various breakthroughs in life science research, from decoding the genome of E. coli to revolutionary CRISPR-Cas genome editing. The company's unwavering dedication to harnessing cutting-edge technology has positioned it as a leader in the biotechnology industry. As the company continues to strive for a brighter future in biological research, its track record and commitment to excellence make it an attractive investment opportunity for venture capital firms seeking to support advancements in the field of biotechnology.
There is no investment information
No recent news or press coverage available for Beijing SBS Genetech Co., Ltd..